Working Group 7: Exploring how interactions between the gut, the immune system and the brain across the life course regulate neurodevelopment and neurodegeneration
Exploring how interactions between the gut, the immune system and the brain across the life course regulate neurodevelopment and neurodegeneration.
We are a diverse group of researchers interested in questions such as: How do diet, microbes, the gut, and the immune system regulate neurodevelopment in early life? How does ageing influence our gut, immune system and brain in later life? Do changes in the microbiota and gut physiology contribute to the development of dementias? Can we modify gut-immune-brain interactions to delay or prevent the onset of neurodegenerative conditions such as Alzheimer’s and Parkinson’s disease? What model systems can we exploit to investigate these questions and how can we translate findings from in vitro and animal studies to humans? We meet monthly to share and discuss our research, and to develop resources for both researchers and the public.
Working Group Leads
James Conway
Research Fellow at the UK DRI at UCL
James is a Research Fellow in the Bartels lab at the UK Dementia Research Institute at UCL, working on gut–brain axis spreading of alpha-synuclein. He is a co-lead of the UK GIBA network’s working group on ageing and neurodegeneration, and he also runs a PPI group in collaboration with Parkinson’s UK.
He completed his PhD in 2024 in the Kramer lab at the University of Plymouth’s Derriford Research Facility. His research focused on the role of the E3 ubiquitin protein ligases NEDD4-1 and NEDD4-2 in the mouse dopaminergic midbrain and their crosstalk with alpha-synuclein. He was also the Alzheimer’s Research UK early career research representative for the University of Plymouth.
Marta Camacho
Senior Research Fellow at the University of Cambridge
More Info